NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

痙攣狀態 - 流行病學的預測(2027年)

Spasticity - Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 534996
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 2-10個工作天內
價格
痙攣狀態 - 流行病學的預測(2027年) Spasticity - Epidemiology Forecast to 2028
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的痙攣狀態的總患病數,2015年673萬6,604人被估計。

本報告提供痙攣狀態的相關調查,疾病概要,患者背景,主要7個國家(美國,英國,德國,法國,義大利,西班牙,日本)的患病數趨勢(過去3年、今後10年份),流行病學的預測,成長要素及市場障礙,今後的市場機會等總括性彙整。

目錄

第1章 摘要整理

第2章 概要

  • 症狀
  • 診斷
  • 病理生理學
  • 腦性麻痺的痙攣狀態
  • 多發性硬化症的痙攣狀態
  • 創傷性腦損傷的痙攣狀態
  • 腦膜炎的痙攣狀態
  • 肌肉萎縮性側索硬化症(ALS)的痙攣狀態
  • 管理

第3章 流行病學

  • 痙攣狀態的流行病學
    • 主要的觀察
    • 主要7個國家痙攣狀態的流行病學
    • 主要7個國家痙攣狀態的患病數
  • 美國
    • 前提和根據
    • 痙攣狀態的患病數
    • 痙攣狀態的患病數:性別
    • ALS的痙攣狀態的患病數
    • 腦膜炎的痙攣狀態的患病數
    • 多發性硬化症的痙攣狀態的患病數
    • 中風的痙攣狀態的患病數
    • 創傷性腦損傷的痙攣狀態的患病數
  • 歐盟5國
    • 法國
      • 前提和根據
      • 痙攣狀態的患病數
      • 痙攣狀態的患病數:性別
      • ALS的痙攣狀態的患病數
      • 腦膜炎的痙攣狀態的患病數
      • 多發性硬化症的痙攣狀態的患病數
      • 中風的痙攣狀態的患病數
      • 創傷性腦損傷的痙攣狀態的患病數
    • 德國
      • 前提和根據
      • 痙攣狀態的患病數
      • 痙攣狀態的患病數:性別
      • ALS的痙攣狀態的患病數
      • 腦膜炎的痙攣狀態的患病數
      • 多發性硬化症的痙攣狀態的患病數
      • 中風的痙攣狀態的患病數
      • 創傷性腦損傷的痙攣狀態的患病數
    • 義大利
      • 前提和根據
      • 痙攣狀態的患病數
      • 痙攣狀態的患病數:性別
      • ALS的痙攣狀態的患病數
      • 腦膜炎的痙攣狀態的患病數
      • 多發性硬化症的痙攣狀態的患病數
      • 中風的痙攣狀態的患病數
      • 創傷性腦損傷的痙攣狀態的患病數
    • 西班牙
      • 前提和根據
      • 痙攣狀態的患病數
      • 痙攣狀態的患病數:性別
      • ALS的痙攣狀態的患病數
      • 腦膜炎的痙攣狀態的患病數
      • 多發性硬化症的痙攣狀態的患病數
      • 中風的痙攣狀態的患病數
      • 創傷性腦損傷的痙攣狀態的患病數
    • 英國
      • 前提和根據
      • 痙攣狀態的患病數
      • 痙攣狀態的患病數:性別
      • ALS的痙攣狀態的患病數
      • 腦膜炎的痙攣狀態的患病數
      • 多發性硬化症的痙攣狀態的患病數
      • 中風的痙攣狀態的患病數
      • 創傷性腦損傷的痙攣狀態的患病數
  • 日本
    • 前提和根據
    • 痙攣狀態的患病數
    • 痙攣狀態的患病數:性別
    • ALS的痙攣狀態的患病數
    • 腦膜炎的痙攣狀態的患病數
    • 多發性硬化症的痙攣狀態的患病數
    • 中風的痙攣狀態的患病數
    • 創傷性腦損傷的痙攣狀態的患病數

第4章 附錄

目錄
Product Code: DIEI0222

DelveInsight's "Spasticity - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Spasticity epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Spasticity Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Spasticity in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Spasticity outlook. It also includes the explanation of changing trends of epidemiology outlining the Spasticity scenario.

Spasticity Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Spasticity thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Spasticity explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Spasticity Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Spasticity

Key assessments

  • Patient Segmentation in Spasticity
  • Spasticity Risk & Burden
  • Factors driving growth in a specific Spasticity patient population

Table of Contents

1. Report Introduction

2. Spasticity Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Spasticity in 2016
  • 2.2. Patient Share Distribution of Spasticity in 2028

3. Disease Background and Overview: Spasticity

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Spasticity in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Spasticity in 7MM - By Countries

5. Epidemiology of Spasticity by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Spasticity
    • 5.1.3. Sub-Type Specific cases of the Spasticity *
    • 5.1.4. Sex- Specific Cases of the Spasticity *
    • 5.1.5. Diagnosed Cases of the Spasticity
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Spasticity
    • 5.4.3. Sub-Type Specific cases of the Spasticity *
    • 5.4.4. Sex- Specific Cases of the Spasticity *
    • 5.4.5. Diagnosed Cases of the Spasticity
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Spasticity
    • 5.5.3. Sub-Type Specific cases of the Spasticity *
    • 5.5.4. Sex- Specific Cases of the Spasticity *
    • 5.5.5. Diagnosed Cases of the Spasticity
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Spasticity
    • 5.6.3. Sub-Type Specific cases of the Spasticity *
    • 5.6.4. Sex- Specific Cases of the Spasticity *
    • 5.6.5. Diagnosed Cases of the Spasticity
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Spasticity
    • 5.7.3. Sub-Type Specific cases of the Spasticity *
    • 5.7.4. Sex- Specific Cases of the Spasticity *
    • 5.7.5. Diagnosed Cases of the Spasticity
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Spasticity
    • 5.8.3. Sub-Type Specific cases of the Spasticity *
    • 5.8.4. Sex- Specific Cases of the Spasticity *
    • 5.8.5. Diagnosed Cases of the Spasticity
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Spasticity
    • 5.9.3. Sub-Type Specific cases of the Spasticity *
    • 5.9.4. Sex- Specific Cases of the Spasticity *
    • 5.9.5. Diagnosed Cases of the Spasticity

6. Unmet Needs of the Spasticity

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Spasticity in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Spasticity in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Spasticity in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Spasticity in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Spasticity in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Spasticity in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Spasticity in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Spasticity in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Spasticity in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Spasticity in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Spasticity in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Spasticity in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Spasticity in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Spasticity in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Spasticity in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Spasticity in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Spasticity in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Spasticity in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Spasticity in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Spasticity in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Spasticity in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Spasticity in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Spasticity in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Spasticity in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Spasticity in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Spasticity in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Spasticity in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Spasticity in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Spasticity in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Spasticity in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Spasticity in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Spasticity in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Spasticity in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Spasticity in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Spasticity in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Spasticity in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Spasticity in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Spasticity in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Spasticity in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Spasticity in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Spasticity in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Spasticity in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Spasticity in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Spasticity in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Spasticity in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Spasticity in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Spasticity in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Spasticity in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Spasticity in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Spasticity in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Spasticity in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Spasticity in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Spasticity in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Spasticity in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Spasticity in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Spasticity in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Spasticity in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Spasticity in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Spasticity in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Spasticity in Japan (2016-2028)